T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CY
951
DELISTED
Cypress Semiconductor
CY
| $40.9M | 0.01% |
1,838,581
-977,135
| -35% | -$17.7M |
|
|
QTS
952
DELISTED
QTS REALTY TRUST, INC.
QTS
| $40.9M | 0.01% |
884,682
+84,905
| +11% | +$3.87M |
|
953
PBF Energy
PBF
$8.34B
| $40.8M | 0.01% |
1,303,631
-330
| -0% | -$9.85K |
|
954
Ubiquiti
UI
$35B
| $40.7M | 0.01% |
309,573
+5,758
| +2% | +$834K |
|
955
nVent Electric
NVT
$27.7B
| $40.7M | 0.01% |
1,641,283
-875,276
| -35% | -$22.5M |
|
956
Arthur J. Gallagher & Co
AJG
$65.5B
| $40.4M | 0.01% |
460,985
-65,711
| -12% | -$5.48M |
|
957
Jack Henry & Associates
JKHY
$10.8B
| $40.1M | 0.01% |
299,206
-2,955
| -1% | -$409K |
|
|
PPL
958
PPL Corp
PPL
$26.7B
| $40M | 0.01% |
1,290,676
+2,358
| +0.2% | +$73.1K |
|
959
Patrick Industries
PATK
$2.79B
| $39.8M | 0.01% |
1,214,324
+31,544
| +3% | +$988K |
|
960
MongoDB
MDB
$35.2B
| $39.7M | 0.01% |
261,182
+257,846
| +7,729% | +$37.4M |
|
961
Suncor Energy
SU
$74.7B
| $39.5M | 0.01% |
1,269,030
-18,935
| -1% | -$606K |
|
962
Q2 Holdings
QTWO
$3.9B
| $39.4M | 0.01% |
515,917
-205,739
| -29% | -$14.9M |
|
963
Ligand Pharmaceuticals
LGND
$5.85B
| $39.3M | 0.01% |
552,012
+2,359
| +0.4% | +$174K |
|
964
Emergent Biosolutions
EBS
$233M
| $39.3M | 0.01% |
813,233
-2,424
| -0.3% | -$116K |
|
965
XPO
XPO
$24.5B
| $39.2M | 0.01% |
1,961,828
-18,068
| -0.9% | -$368K |
|
|
ZGNX
966
DELISTED
Zogenix, Inc.
ZGNX
| $39.2M | 0.01% |
820,149
-823,331
| -50% | -$33.2M |
|
967
Fastenal
FAST
$59.9B
| $39.1M | 0.01% |
2,400,376
-2,564
| -0.1% | -$42.3K |
|
|
AAT
968
American Assets Trust
AAT
$1.39B
| $39.1M | 0.01% |
830,026
+136,547
| +20% | +$6.28M |
|
|
ADSW
969
DELISTED
Advanced Disposal Services Inc
ADSW
| $39M | 0.01% |
1,223,690
-14,787
| -1% | -$465K |
|
|
CCF
970
DELISTED
Chase Corporation
CCF
| $39M | 0.01% |
362,501
-1,728
| -0.5% | -$171K |
|
971
Quanex
NX
$1B
| $39M | 0.01% |
2,061,964
+2,000
| +0.1% | +$33.5K |
|
972
PENN Entertainment
PENN
$2.57B
| $39M | 0.01% |
2,022,322
+181,077
| +10% | +$3.67M |
|
973
CDW
CDW
$17.1B
| $38.9M | 0.01% |
350,481
-11,976
| -3% | -$1.26M |
|
|
CISN
974
DELISTED
Cision Ltd. Ordinary Share
CISN
| $38.8M | 0.01% |
3,306,267
-6,563,637
| -67% | -$77.8M |
|
|
CHUY
975
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $38.6M | 0.01% |
1,682,479
+1,459
| +0.1% | +$31.4K |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.